Warning: The NCBI web site requires JavaScript to function. more...
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R.
Breast Cancer Res. 2008;10(3):R48. Epub 2008 May 29.
Related citations
SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Zeidan BA, Townsend PA.
Breast Cancer Res. 2008;10(3):107.
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
Gonçalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D.
Mol Cell Proteomics. 2008 Aug;7(8):1420-33. Epub 2008 Apr 20.
Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.
Clin Invest Med. 2006 Jun;29(3):136-45.
Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Lim JY, Cho JY, Paik YH, Chang YS, Kim HG.
Int J Biol Markers. 2007 Oct-Dec;22(4):281-6.
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P.
Proteomics. 2006 Mar;6(6):1963-75.
Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.
BMC Cancer. 2005 Jul 20;5:83.
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP, Shen J, Li ZF, Yan L, Gu J.
Cancer Invest. 2006 Dec;24(8):747-53.
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H, Dragan Y, Epstein J, Teitel C, Chen B, Xie Q, Fang H, Shi L, Perkins R, Tong W.
BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S5.
SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.
[Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ, Du J, Pang D.
Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):204-7. Chinese.
Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI, He F, Cutrufello NJ, Lidow MS.
Neurobiol Dis. 2006 Jul;23(1):61-76. Epub 2006 Mar 20.
Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
Wang Q, Shen J, Li ZF, Jie JZ, Wang WY, Wang J, Zhang ZT, Li ZX, Yan L, Gu J.
BMC Cancer. 2009 Aug 19;9:287.
The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC.
Clin Cancer Res. 2004 Jul 15;10(14):4806-12.
Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.
Jpn J Clin Oncol. 2010 Apr;40(4):336-42. Epub 2010 Jan 20.
Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH, Zhang S, Cui JF, Lu B, Dong XH, Song XY, Liu YK, Zhu XX, Hu RM.
Diabet Med. 2007 Dec;24(12):1386-92.
Clinical proteomics in breast cancer: a review.
Gast MC, Schellens JH, Beijnen JH.
Breast Cancer Res Treat. 2009 Jul;116(1):17-29. Epub 2008 Dec 11. Review.
Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.
Am J Clin Oncol. 2008 Apr;31(2):133-9.
[Proteomics and breast cancer].
Mathelin C, Tomasetto C, Cromer A, Rio MC.
Gynecol Obstet Fertil. 2006 Dec;34(12):1161-9. Epub 2006 Nov 22. Review. French.
Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ, Lovell MO, Izbicka E.
Mod Pathol. 2004 Aug;17(8):1012-20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on